Oral Proteins and Peptides Market

Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking ?-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.
Oral Proteins and Peptides Market contains market size and forecasts of Oral Proteins and Peptides in global, including the following market information:
Global Oral Proteins and Peptides Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oral Proteins and Peptides Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Oral Proteins and Peptides companies in 2021 (%)
The global Oral Proteins and Peptides market was valued at 2576 million in 2021 and is projected to reach US$ 6614.7 million by 2028, at a CAGR of 14.4% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Linaclotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Proteins and Peptides include Ironwood & Allergan, Novo Nordisk, Synergy Pharmaceuticals ?Salix?, Novartis and Chiasma (Amryt Pharma), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Proteins and Peptides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Proteins and Peptides Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Oral Proteins and Peptides Market Segment Percentages, by Type, 2021 (%)
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Global Oral Proteins and Peptides Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Oral Proteins and Peptides Market Segment Percentages, by Application, 2021 (%)
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Global Oral Proteins and Peptides Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Oral Proteins and Peptides Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Proteins and Peptides revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oral Proteins and Peptides revenues share in global market, 2021 (%)
Key companies Oral Proteins and Peptides sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Oral Proteins and Peptides sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ironwood & Allergan
Novo Nordisk
Synergy Pharmaceuticals ?Salix?
Novartis
Chiasma (Amryt Pharma)